David Lawrence
2014
In 2014, David Lawrence earned a total compensation of $1.4M as Chief, Business Operations and Principal Accounting Officer at Acorda Therapeutics, a 18% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $185,294 |
|---|---|
| Option Awards | $654,330 |
| Salary | $341,000 |
| Stock Awards | $236,280 |
| Other | $7,650 |
| Total | $1,424,554 |
Lawrence received $654.3K in option awards, accounting for 46% of the total pay in 2014.
Lawrence also received $185.3K in non-equity incentive plan, $341K in salary, $236.3K in stock awards and $7.7K in other compensation.
Rankings
In 2014, David Lawrence's compensation ranked 6,002nd out of 13,032 executives tracked by ExecPay. In other words, Lawrence earned more than 53.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,002 out of 13,032 | 54th |
Division Manufacturing | 2,173 out of 4,966 | 56th |
Major group Chemicals And Allied Products | 724 out of 1,686 | 57th |
Industry group Drugs | 563 out of 1,365 | 59th |
Industry Biological Products, Except Diagnostic Substances | 104 out of 236 | 56th |
Source: SEC filing on April 21, 2017.
Lawrence's colleagues
We found six more compensation records of executives who worked with David Lawrence at Acorda Therapeutics in 2014.
2014
Andrew Hindman
Acorda Therapeutics
Chief Business Development Officer
2014
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2014
Jane Wasman
Acorda Therapeutics
General Counsel
2014
Enrique Carrazana
Acorda Therapeutics
Chief Medical Officer
2014
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2014
Michael Rogers
Acorda Therapeutics